Topoisomerase iia binding domains of adenomatous polyposis coli influence cell cycle progression and aneuploidy

PLoS ONE

Volumn 5, Issue 4, 2010, Pages

  Wang, Yang ^a   Coffey, Robert J ^b,c   Osheroff, Neil ^b   Neufeld, Kristi L ^a  

^a UNIVERSITY OF KANSAS   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID DERIVATIVE; APC PROTEIN; BETA CATENIN; DNA TOPOISOMERASE (ATP HYDROLYSING); ISOENZYME; TOPOISOMERASE IIALPHA; TOPOISOMERASE IIBETA; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; DNA TOPOISOMERASE II ALPHA; TUMOR ANTIGEN;

ANEUPLOIDY; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE PROGRESSION; COLON CANCER; COLON MUCOSA; COLON POLYPOSIS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BINDING; EPITHELIUM CELL; HUMAN; HUMAN CELL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; BINDING SITE; CELL CYCLE; ENZYMOLOGY; GENETICS; METABOLISM; NUCLEOTIDE REPEAT; PATHOLOGY; STOP CODON; TUMOR CELL LINE;

ADENOMATOUS POLYPOSIS COLI; ADENOMATOUS POLYPOSIS COLI PROTEIN; ANEUPLOIDY; ANTIGENS, NEOPLASM; BETA CATENIN; BINDING SITES; CELL CYCLE; CELL LINE, TUMOR; CODON, NONSENSE; DNA TOPOISOMERASES, TYPE II; DNA-BINDING PROTEINS; EPITHELIAL CELLS; G2 PHASE; HUMANS; REPETITIVE SEQUENCES, NUCLEIC ACID;

EID: 77956310444     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0009994     Document Type: Article

References (53)

1. Kinzler KW, Vogelstein B (1996) Lessons from hereditary colorectal cancer. Cell 87: 159-170.
2. Cardoso J, Molenaar L, de Menezes RX, van Leerdam M, Rosenberg C, et al. (2006) Chromosomal instability in MYH- and APC-mutant adenomatous polyps. Cancer Res 66: 2514-2519.
3. Svendsen LB (1993) Congenital genetic instability in colorectal carcinomas. Dan Med Bull 40: 546-556.
4. Quirke P, Dixon MF, Day DW, Fozard JB, Talbot IC, et al. (1988) DNA aneuploidy and cell proliferation in familial adenomatous polyposis. Gut 29: 603-607.
5. Aberle H, Bauer A, Stappert J, Kispert A, Kemler R (1997) b-catenin is a target for the ubiquitin-proteasome pathway. EMBO J 16: 3797-3804.
6. Behrens J, Jerchow BA, Wurtele M, Grimm J, Asbrand C, et al. (1998) Functional interaction of an axin homolog, conductin, with beta- catenin, APC, and GSK3beta. Science 280: 596-599.
7. Hart MJ, de los Santos R, Albert IN, Rubinfeld B, Polakis P (1998) Downregulation of beta-catenin by human Axin and its association with the APC tumor suppressor, beta-catenin and GSK3 beta. Curr Biol 8: 573-581.
8. Ikeda S, Kishida S, Yamamoto H, Murai H, Koyama S, et al. (1998) Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta- dependent phosphorylation of beta-catenin. EMBO J 17: 1371-1384.
9. Nakamura T, Hamada F, Ishidate T, Anai K, Kawahara K, et al. (1998) Axin, an inhibitor of the Wnt signalling pathway, interacts with beta-catenin, GSK-3beta and APC and reduces the beta-catenin level. Genes Cells 3: 395-403.
10. Aoki K, Taketo MM (2007) Adenomatous polyposis coli (APC): a multifunctional tumor suppressor gene. J Cell Sci 120: 3327-3335.
11. Jaiswal AS, Narayan S (2004) Zinc stabilizes adenomatous polyposis coli (APC) protein levels and induces cell cycle arrest in colon cancer cells. J Cell Biochem 93: 345-357.
12. Olmeda D, Castel S, Vilaro S, Cano A (2003) Beta-catenin regulation during the cell cycle: implications in G2/M and apoptosis. Mol Biol Cell 14: 2844-2860.
13. Heinen CD, Goss KH, Cornelius JR, Babcock GF, Knudsen ES, et al. (2002) The APC tumor suppressor controls entry into S-phase through its ability to regulate the cyclin D/RB pathway. Gastroenterology 123: 751-763.
14. Kaplan KB, Burds AA, Swedlow JR, Bekir SS, Sorger PK, et al. (2001) A role for the Adenomatous Polyposis Coli protein in chromosome segregation. Nat Cell Biol 3: 429-432.
15. Fodde R, Kuipers J, Rosenberg C, Smits R, Kielman M, et al. (2001) Mutations in the APC tumour suppressor gene cause chromosomal instability. Nat Cell Biol 3: 433-438.
16. Ishidate T, Matsumine A, Toyoshima K, Akiyama T (2000) The APC-hDLG complex negatively regulates cell cycle progression from the G0/G1 to S phase. Oncogene 19: 365-372.
17. Bhattacharjee RN, Hamada F, Toyoshima K, Akiyama T (1996) The tumor suppressor gene product APC is hyperphosphorylated during the M phase. Biochem Biophys Res Commun 220: 192-195.
18. Wang Y, Azuma Y, Moore D, Osheroff N, Neufeld KL (2008) Interaction between tumor suppressor adenomatous polyposis coli and topoisomerase IIalpha: implication for the G2/M transition. Mol Biol Cell 19: 4076-4085.
19. McClendon AK, Osheroff N (2007) DNA topoisomerase II, genotoxicity, and cancer. Mutat Res 623: 83-97.
20. Fortune JM, Osheroff N (2001) Topoisomerase II-catalyzed relaxation and catenation of plasmid DNA. Methods Mol Biol 95: 275-281.
21. Champoux JJ (2001) DNA topoisomerases: structure, function, and mechanism. Annu Rev Biochem 70: 369-413.
22. Wang JC (1996) DNA topoisomerases. Annu Rev Biochem 65: 635-692.
23. Downes CS, Clarke DJ, Mullinger AM, Gimenez-Abian JF, Creighton AM, et al. (1994) A topoisomerase II-dependent G2 cycle checkpoint in mammalian cells. Nature 372: 467-470.
24. Akimitsu N, Adachi N, Hirai H, Hossain MS, Hamamoto H, et al. (2003) Enforced cytokinesis without complete nuclear division in embryonic cells depleting the activity of DNA topoisomerase IIalpha. Genes Cells 8: 393-402.
25. Yang X, Li W, Prescott ED, Burden SJ, Wang JC (2000) DNA topoisomerase IIbeta and neural development. Science 287: 131-134.
26. Grue P, Grasser A, Sehested M, Jensen PB, Uhse A, et al. (1998) Essential mitotic functions of DNA topoisomerase IIalpha are not adopted by topoisomerase IIbeta in human H69 cells. J Biol Chem 273: 33660-33666.
27. Neufeld KL (2009) Nuclear Functions of APC. Adv Exp Med Biol 656: 13-29.
28. Taylor WR, Stark GR (2001) Regulation of the G2/M transition by p53. Oncogene 20: 1803-1815.
29. Wolf D, Rotter V (1985) Major deletions in the gene encoding the p53 tumor antigen cause lack of p53 expression in HL-60 cells. Proc Natl Acad Sci U S A 82: 790-794.
30. Carpenter AJ, Porter AC (2004) Construction, characterization, and complementation of a conditional-lethal DNA topoisomerase IIalpha mutant human cell line. Mol Biol Cell 15: 5700-5711.
31. Harker WG, Slade DL, Dalton WS, Meltzer PS, Trent JM (1989) Multidrug resistance in mitoxantrone-selected HL-60 leukemia cells in the absence of Pglycoprotein overexpression. Cancer Res 49: 4542-4549.
32. Harker WG, Slade DL, Parr RL, Holguin MH (1995) Selective use of an alternative stop codon and polyadenylation signal within intron sequences leads to a truncated topoisomerase II alpha messenger RNA and protein in human HL-60 leukemia cells selected for resistance to mitoxantrone. Cancer Res 55: 4962-4971.
33. Harker WG, Slade DL, Parr RL, Feldhoff PW, Sullivan DM, et al. (1995) Alterations in the topoisomerase II alpha gene, messenger RNA, and subcellular protein distribution as well as reduced expression of the DNA topoisomerase II beta enzyme in a mitoxantrone-resistant HL-60 human leukemia cell line. Cancer Res 55: 1707-1716.
34. Harker WG, Slade DL, Drake FH, Parr RL (1991) Mitoxantrone resistance in HL-60 leukemia cells: reduced nuclear topoisomerase II catalytic activity and drug-induced DNA cleavage in association with reduced expression of the topoisomerase II beta isoform. Biochemistry 30: 9953-9961.
35. Chan TA, Wang Z, Dang LH, Vogelstein B, Kinzler KW (2002) Targeted inactivation of CTNNB1 reveals unexpected effects of beta-catenin mutation. Proc Natl Acad Sci U S A 99: 8265-8270.
36. Rosin-Arbesfeld R, Cliffe A, Brabletz T, Bienz M (2003) Nuclear export of the APC tumour suppressor controls beta-catenin function in transcription. Embo J 22: 1101-1113.
37. Rusan N, Peifer M (2008) Original CIN: reviewing roles for APC in chromosome instability. J Cell Biol 181: 719-726.
38. Zhang J, Neisa R, Mao Y (2009) Oncogenic Adenomatous Polyposis Coli Mutants Impair the Mitotic Checkpoint through Direct Interaction with Mad2. Mol Biol Cell 20: 2381-2388.
39. Ishida R, Sato M, Narita T, Utsumi KR, Nishimoto T, et al. (1994) Inhibition of DNA topoisomerase II by ICRF-193 induces polyploidization by uncoupling chromosome dynamics from other cell cycle events. J Cell Biol 126: 1341-1351.
40. Gorbsky GJ (1994) Cell cycle progression and chromosome segregation in mammalian cells cultured in the presence of the topoisomerase II inhibitors ICRF-187 [(+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane; ADR-529] and ICRF-159 (Razoxane). Cancer Res 54: 1042-1048.
41. Sugimoto K, Sasaki M, Isobe Y, Tsutsui M, Suto H, et al. (2008) Hsp90- inhibitor geldanamycin abrogates G2 arrest in p53-negative leukemia cell lines through the depletion of Chk1. Oncogene 27: 3091-3101.
42. Skoufias DA, Lacroix FB, Andreassen PR, Wilson L, Margolis RL (2004) Inhibition of DNA decatenation, but not DNA damage, arrests cells at metaphase. Mol Cell 15: 977-990.
43. Watanabe T, Wang S, Noritake J, Sato K, Fukata M, et al. (2004) Interaction with IQGAP1 links APC to Rac1, Cdc42, and actin filaments during cell polarization and migration. Dev Cell 7: 871-883.
44. Kingma PS, Greider CA, Osheroff N (1997) Spontaneous DNA lesions poison human topoisomerase IIalpha and stimulate cleavage proximal to leukemic 11q23 chromosomal breakpoints. Biochemistry 36: 5934-5939.
45. Worland ST, Wang JC (1989) Inducible overexpression, purification, and active site mapping of DNA topoisomerase II from the yeast Saccharomyces cerevisiae. J Biol Chem 264: 4412-4416.
46. Zhang F, White RL, Neufeld KL (2001) Cell density and phosphorylation control the subcellular localization of adenomatous polyposis coli protein. Mol Cell Biol 21: 8143-8156.
47. Woodford-Richens KL, Rowan AJ, Gorman P, Halford S, Bicknell DC, et al. (2001) SMAD4 Mutations in Colorectal Cancer Probably Occur Before Chromosomal Instability, but After Divergence of the Microsatellite Instability Pathway. Proc Natl Acad Sci USA 98: 9719-9723.
48. Abdel-Rahman WM, Katsura K, Rens W, Gorman PA, Sheer D, et al. (2001) Spectral karyotyping suggests additional subsets of colorectal cancers characterized by pattern of chromosome rearrangement. Proc Natl Acad Sci U S A 98: 2538-2543.
49. Kleivi K, Teixeira M, Eknaes M, Diep C, Jakobsen K, et al. (2004) Genome signatures of colon carcinoma cell lines. Cancer Genet Cytogenet 155: 119-131.
50. NCI and NCBI's SKY/M-FISH and CGH Database 2001: http://www.ncbi.nlm.nih.gov/sky/skyweb.cgi.
51. Lengauer C, Kinzler KW, Vogelstein B (1997) Genetic instability in colorectal cancers. Nature 386: 623-627.
52. Rowan AJ, Lamlum H, Ilyas M, Wheeler J, Straub J, et al. (2000) APC mutations in sporadic colorectal tumors: A mutational hotspot and interdependence of the two hits". Proc Natl Acad Sci U S A 97: 3352-3357.
53. Dang D, Mahatan C, Dang L, Agboola I, Yang V (2001) Expression of the gutenriched Kruppel-like factor (Kruppel-like factor 4) gene in the human colon cancer cell line RKO is dependent on CDX2. Oncogene 20: 4884-4890.